Green Cross Holdings Corporation (005250.KS)
KRW 13380.0
(3.72%)
KRW 13380.0
(3.72%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 216.35 Billion KRW | -55.23% |
| 2022 | 483.2 Billion KRW | 11.15% |
| 2021 | 434.71 Billion KRW | 98.66% |
| 2020 | 218.82 Billion KRW | -53.41% |
| 2019 | 469.65 Billion KRW | 13.2% |
| 2018 | 414.87 Billion KRW | -7.94% |
| 2017 | 450.65 Billion KRW | 79.5% |
| 2016 | 251.05 Billion KRW | 101.25% |
| 2015 | 124.75 Billion KRW | 139.39% |
| 2014 | 52.11 Billion KRW | -14.71% |
| 2013 | 61.1 Billion KRW | 100.3% |
| 2012 | 30.5 Billion KRW | -78.99% |
| 2011 | 145.21 Billion KRW | -19.15% |
| 2010 | 179.61 Billion KRW | 142.83% |
| 2009 | 73.96 Billion KRW | -3.67% |
| 2008 | 76.78 Billion KRW | -27.25% |
| 2007 | 105.54 Billion KRW | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 418.75 Billion KRW | 11.39% |
| 2024 Q1 | 375.91 Billion KRW | 73.75% |
| 2023 Q2 | 244.53 Billion KRW | -48.34% |
| 2023 FY | 216.35 Billion KRW | -55.23% |
| 2023 Q3 | 256.35 Billion KRW | 4.84% |
| 2023 Q4 | 216.35 Billion KRW | -15.61% |
| 2023 Q1 | 473.32 Billion KRW | -2.05% |
| 2022 Q4 | 483.2 Billion KRW | -0.49% |
| 2022 Q2 | 484.59 Billion KRW | 9.36% |
| 2022 FY | 483.2 Billion KRW | 11.15% |
| 2022 Q1 | 443.11 Billion KRW | 1.93% |
| 2022 Q3 | 485.57 Billion KRW | 0.2% |
| 2021 Q3 | 430.98 Billion KRW | 0.14% |
| 2021 Q2 | 430.36 Billion KRW | 94.65% |
| 2021 Q4 | 434.71 Billion KRW | 0.87% |
| 2021 FY | 434.71 Billion KRW | 98.66% |
| 2021 Q1 | 221.09 Billion KRW | 1.04% |
| 2020 FY | 218.82 Billion KRW | -53.41% |
| 2020 Q4 | 218.82 Billion KRW | -12.0% |
| 2020 Q2 | 492.62 Billion KRW | 8.55% |
| 2020 Q1 | 453.81 Billion KRW | -3.37% |
| 2020 Q3 | 248.66 Billion KRW | -49.52% |
| 2019 Q4 | 469.65 Billion KRW | 3.61% |
| 2019 FY | 469.65 Billion KRW | 13.2% |
| 2019 Q1 | 431.24 Billion KRW | 3.95% |
| 2019 Q2 | 466.93 Billion KRW | 8.28% |
| 2019 Q3 | 453.27 Billion KRW | -2.93% |
| 2018 Q2 | 393.3 Billion KRW | -13.25% |
| 2018 Q1 | 453.37 Billion KRW | 0.61% |
| 2018 FY | 414.87 Billion KRW | -7.94% |
| 2018 Q4 | 414.87 Billion KRW | 11.23% |
| 2018 Q3 | 372.97 Billion KRW | -5.17% |
| 2017 Q4 | 450.65 Billion KRW | -5.63% |
| 2017 Q2 | 456.1 Billion KRW | 66.75% |
| 2017 Q1 | 273.53 Billion KRW | 8.95% |
| 2017 FY | 450.65 Billion KRW | 79.5% |
| 2017 Q3 | 477.52 Billion KRW | 4.7% |
| 2016 Q4 | 251.05 Billion KRW | 12.29% |
| 2016 Q3 | 223.58 Billion KRW | 10.81% |
| 2016 Q2 | 201.76 Billion KRW | 118.66% |
| 2016 Q1 | 92.27 Billion KRW | -26.03% |
| 2016 FY | 251.05 Billion KRW | 101.25% |
| 2015 FY | 124.75 Billion KRW | 139.39% |
| 2015 Q1 | 113.05 Billion KRW | 116.94% |
| 2015 Q2 | 79.8 Billion KRW | -29.41% |
| 2015 Q3 | 54.79 Billion KRW | -31.34% |
| 2015 Q4 | 124.75 Billion KRW | 127.68% |
| 2014 Q4 | 52.11 Billion KRW | 1.86% |
| 2014 Q3 | 51.16 Billion KRW | -26.02% |
| 2014 Q2 | 69.15 Billion KRW | 17.61% |
| 2014 Q1 | 58.8 Billion KRW | -3.77% |
| 2014 FY | 52.11 Billion KRW | -14.71% |
| 2013 FY | 61.1 Billion KRW | 100.3% |
| 2013 Q1 | 23.01 Billion KRW | -24.54% |
| 2013 Q2 | 18.83 Billion KRW | -18.17% |
| 2013 Q3 | 16.55 Billion KRW | -12.12% |
| 2013 Q4 | 61.1 Billion KRW | 269.12% |
| 2012 FY | 30.5 Billion KRW | -78.99% |
| 2012 Q3 | 52.48 Billion KRW | 5.64% |
| 2012 Q4 | 30.5 Billion KRW | -41.88% |
| 2012 Q1 | 49.85 Billion KRW | -65.67% |
| 2012 Q2 | 49.68 Billion KRW | -0.33% |
| 2011 FY | 145.21 Billion KRW | -19.15% |
| 2011 Q4 | 145.21 Billion KRW | -0.5% |
| 2011 Q3 | 145.94 Billion KRW | -15.53% |
| 2011 Q2 | 172.77 Billion KRW | -4.97% |
| 2011 Q1 | 181.81 Billion KRW | 0.0% |
| 2010 Q3 | 65.5 Billion KRW | 0.0% |
| 2010 FY | 179.61 Billion KRW | 142.83% |
| 2010 Q1 | - KRW | 0.0% |
| 2010 Q2 | 65.5 Billion KRW | 0.0% |
| 2009 FY | 73.96 Billion KRW | -3.67% |
| 2009 Q3 | - KRW | 0.0% |
| 2009 Q2 | - KRW | 0.0% |
| 2009 Q1 | - KRW | 0.0% |
| 2008 Q2 | 53.55 Billion KRW | -11.93% |
| 2008 Q3 | 49.63 Billion KRW | -7.32% |
| 2008 FY | 76.78 Billion KRW | -27.25% |
| 2008 Q1 | 60.8 Billion KRW | 0.0% |
| 2007 FY | 105.54 Billion KRW | 0.0% |
| 2007 Q1 | 28.21 Billion KRW | 0.0% |
| 2007 Q2 | 69.62 Billion KRW | 146.77% |
| 2007 Q3 | 60.73 Billion KRW | -12.78% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| ORIENT BIO Inc. | 2.43 Billion KRW | -8779.408% |
| Green Cross Holdings Corporation | 84.89 Billion KRW | -154.861% |
| Pharmicell Co., Ltd. | 390.21 Million KRW | -55343.875% |
| Green Cross Corporation | 84.89 Billion KRW | -154.861% |
| GeneOne Life Science, Inc. | 6.27 Billion KRW | -3349.064% |
| Celltrion, Inc. | 99.13 Billion KRW | -118.244% |
| Samsung Biologics Co.,Ltd. | 377.39 Billion KRW | 42.672% |
| SK bioscience Co.,Ltd. | 12.43 Billion KRW | -1639.713% |
| SK Biopharmaceuticals Co., Ltd. | 94.48 Billion KRW | -128.983% |
| Prestige BioPharma Limited | 40.87 Billion KRW | -429.35% |